BMJ  2007;335 (8 September), doi:10.1136/bmj.39329.634931.47

Editor's Choice

Editor's Choice

Focus on diabetes

The first 150 words of the full text of this article appear below.

Diabetes affects more than 2 million people in the United Kingdom and more than 170 million across the world. Type 2 diabetes accounts for over 90% of cases. The burden of this condition for patients, their families, and healthcare systems is immense and growing. WHO estimates that global prevalence of diabetes will more than double over the next quarter century to affect 366 million people by 2030.

As diabetes becomes more of a global problem, the debate on whether to introduce population based mass screening is hotting up. Two papers in this week's BMJ from Helen Eborall and colleagues (doi: 10.1136/bmj.39303.723449.55, doi: 10.1136/bmj.39308.392176.BE) explore the psychological effect of screening and find that, with a stepwise approach, it's unlikely to have important adverse effects. This adds wind to the sails of the pro-screening flotilla, but as Ronald Stolk points out in his editorial (doi: 10.1136/bmj.39323.395336.BE), we shouldn't forget . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?

A A Tahrani, G I Varughese, J H Scarpello, and F W F Hanna
BMJ 2007 335: 508-512. [Extract] [Full Text] [PDF]

Self monitoring of blood glucose in type 2 diabetes: longitudinal qualitative study of patients' perspectives

Elizabeth Peel, Margaret Douglas, and Julia Lawton
BMJ 2007 335: 493. [Abstract] [Full Text] [PDF]

Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial

Helen C Eborall, Simon J Griffin, A Toby Prevost, Ann-Louise Kinmonth, David P French, and Stephen Sutton
BMJ 2007 335: 486. [Abstract] [Full Text] [PDF]

Patients' experiences of screening for type 2 diabetes: prospective qualitative study embedded in the ADDITION (Cambridge) randomised controlled trial

Helen Eborall, Richard Davies, Ann-Louise Kinmonth, Simon Griffin, and Julia Lawton
BMJ 2007 335: 490. [Abstract] [Full Text] [PDF]

Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review

Dean T Eurich, Finlay A McAlister, David F Blackburn, Sumit R Majumdar, Ross T Tsuyuki, Janice Varney, and Jeffrey A Johnson
BMJ 2007 335: 497. [Abstract] [Full Text] [PDF]

Screening for diabetes

Ronald P Stolk
BMJ 2007 335: 457-458. [Extract] [Full Text] [PDF]

Self monitoring of blood glucose in type 2 diabetes

Simon R Heller
BMJ 2007 335: 105-106. [Extract] [Full Text] [PDF]

Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial

Andrew Farmer, Alisha Wade, Elizabeth Goyder, Patricia Yudkin, David French, Anthea Craven, Rury Holman, Ann-Louise Kinmonth, and Andrew Neil
BMJ 2007 335: 132. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Recovery from diabetes (in mice) by ß cell regeneration

Jay Ilangaratne
bmj.com, 10 Sep 2007 [Full text]

Online poll

Find out more >>